nitroaspirin has been researched along with Colonic Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ouyang, N; Rigas, B; Williams, JL | 1 |
| Hua, A; Mackenzie, GG; Rigas, B | 1 |
| Amadori, D; Medri, L; Ricotti, L; Tesei, A; Ulivi, P; Zoli, W | 1 |
| Di Napoli, M; Papa, F | 1 |
| Gao, J; Kashfi, K; Liu, X; Rigas, B | 1 |
| Kopelovich, L; Liu, X; Ouyang, N; Patlolla, JM; Rao, CV; Reddy, BS; Rigas, B; Simi, B; Steele, VE; Wang, CX | 1 |
| Bak, AW; Calignano, A; Cirino, G; Del Soldato, P; Li, P; McKnight, W; Wallace, JL | 1 |
1 review(s) available for nitroaspirin and Colonic Neoplasms
| Article | Year |
|---|---|
NCX-4016 NicOx.
Topics: Animals; Aspirin; Cardiovascular Diseases; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Colonic Neoplasms; Cyclooxygenase Inhibitors; Humans; Molecular Structure; Nitric Oxide; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Structure-Activity Relationship | 2003 |
6 other study(ies) available for nitroaspirin and Colonic Neoplasms
| Article | Year |
|---|---|
NO-donating aspirin inhibits angiogenesis by suppressing VEGF expression in HT-29 human colon cancer mouse xenografts.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonic Neoplasms; HT29 Cells; Humans; Immunoenzyme Techniques; Male; Mice; Mice, Nude; Necrosis; Neovascularization, Pathologic; Nitric Oxide Donors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2008 |
The differential cell signaling effects of two positional isomers of the anticancer NO-donating aspirin.
Topics: Activating Transcription Factor 2; Antineoplastic Agents; Aspirin; Cell Cycle; Cell Proliferation; Colonic Neoplasms; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p21; Dose-Response Relationship, Drug; Enzyme Activation; HT29 Cells; Humans; Inhibitory Concentration 50; Isomerism; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Nitric Oxide Donors; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-jun; RNA Interference; Signal Transduction; Structure-Activity Relationship; Time Factors; Transcription Factor AP-1 | 2009 |
NCX 4016, a nitric oxide-releasing aspirin derivative, exhibits a significant antiproliferative effect and alters cell cycle progression in human colon adenocarcinoma cell lines.
Topics: Adenocarcinoma; Anticarcinogenic Agents; Aspirin; Cell Cycle; Cell Division; Cell Survival; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Isoenzymes; Kinetics; Membrane Proteins; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Tumor Cells, Cultured | 2003 |
NO-donating aspirin induces phase II enzymes in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Aspirin; Chemoprevention; Colonic Neoplasms; Enzyme Induction; Female; Glutathione Transferase; Humans; Intracellular Signaling Peptides and Proteins; Kelch-Like ECH-Associated Protein 1; Liver Neoplasms; Mice; Mice, Inbred C57BL; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Nitric Oxide; Proteins; Transplantation, Heterologous | 2006 |
Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Topics: Acetates; Animals; Antineoplastic Agents; Aspirin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Humans; Indoles; Male; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344 | 2006 |
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Aspirin; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Isoenzymes; Male; Membrane Proteins; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1998 |